Clinical trial
Evaluation of the Effect of Dextran Sulphate on Anti-Xa Activities Measured in Patients Treated With Unfractionated Heparin in Different Indications-DEXHEP
NCT04700670 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Effect of Dextran Sulphate on Anti-Xa Activities Measured in Patients Treated With Unfractionated Heparin in Different Indications-DEXHEP
- Lead sponsor
- Rennes University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 16, 2020
- Completion date
- January 16, 2021
- Enrollment
- 164 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
unfractionated heparin treatment